The Emerging Role of Epigenetics on Dietary Treatment for Epilepsy
AuthorsLandgrave Gomez, Jorge
Mercado-Gómez, Octavio Fabian
KAUST DepartmentBiological and Environmental Sciences and Engineering (BESE) Division
Online Publication Date2017-02-15
Print Publication Date2017-03
Permanent link to this recordhttp://hdl.handle.net/10754/623188
MetadataShow full item record
AbstractPurpose of ReviewSeizures are able to induce a wide range of complex alterations that may be due to abnormalities in gene expression patterns. In recent years, there has been resurgence regarding the use of dietary therapies for seizure treatment. Unfortunately, the precise mechanisms by which these therapies exert its effects remain unknown.Recent FindingsRecent evidence suggest that dietary treatment, throughout a metabolic shift, could impact the concentration of some metabolites, such as beta-hydroxybutyrate (B-HB) or S-adenosyl methionine (SAM), which are able to modulate the activity of enzymes involved in regulatory processes that control gene expression. Despite of this evidence, only a few studies have fully explored this emerging field.SummaryThe purpose of this article is to discuss how dietary treatment, throughout these molecules, could influence epigenetic modifications that may be able to restore aberrant patterns of gene expression produced by seizures, having an impact on this complex disease, such as seizures or even in epileptogenesis.
CitationLandgrave-Gómez J, Vargas-Romero F, Mercado-Gómez OF, Guevara-Guzmán R (2017) The Emerging Role of Epigenetics on Dietary Treatment for Epilepsy. Current Nutrition Reports 6: 9–15. Available: http://dx.doi.org/10.1007/s13668-017-0189-7.
JournalCurrent Nutrition Reports